BRUKER CORPORATION Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
BRUKER CORPORATION (BRKR) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2026-08-05
- BRUKER CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2026-06-30 was 0.00 shares.
- BRUKER CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2026-03-31 was 0.00 shares.
- BRUKER CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2025-09-30 was 0.00 shares.
- BRUKER CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2025-06-30 was 0.00 shares.
- BRUKER CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2025 was 0.00 shares.
- BRUKER CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2024 was 0.00 shares.
- BRUKER CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2023 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-05 | 0.00 shares 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-27 | |||
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-05 | 0.00 shares 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-05 | 0.00 shares 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-02-27 | |||
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-05 | 0.00 shares 10-Q · filed 2025-11-05 | ||
| 2023-12-31 | 0.00 shares 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |